Oral Antibiotics and Risk of Serious Cutaneous Adverse Drug Reactions

医学 抗生素 药物反应 皮肤病科 药品 重症监护医学 不利影响 药理学 微生物学 生物
作者
Erika Yue Lee,Tara Gomes,Aaron M. Drucker,Nick Daneman,Ayesha Asaf,Fangyun Wu,Vincent Piguet,David N. Juurlink
出处
期刊:JAMA [American Medical Association]
标识
DOI:10.1001/jama.2024.11437
摘要

Importance Serious cutaneous adverse drug reactions (cADRs) are potentially life-threatening drug hypersensitivity reactions involving the skin and internal organs. Antibiotics are a recognized cause of these reactions, but no studies have compared relative risks across antibiotic classes. Objectives To explore the risk of serious cADRs associated with commonly prescribed oral antibiotics, and to characterize outcomes of patients hospitalized for them. Design, Setting, and Participants Nested case-control study using population-based linked administrative datasets among adults aged 66 years or older who received at least 1 oral antibiotic between 2002 and 2022 in Ontario, Canada. Cases were those who had an emergency department (ED) visit or hospitalization for serious cADRs within 60 days of the prescription, and each case was matched with up to 4 controls who did not. Exposure Various classes of oral antibiotics. Main Outcomes and Measures Conditional logistic regression estimate of the association between different classes of oral antibiotics and serious cADRs, using macrolides as the reference group. Results During the 20-year study period, we identified 21 758 older adults (median age, 75 years; 64.1% female) who had an ED visit or hospitalization for serious cADRs following antibiotic therapy and 87 025 matched controls who did not. In the primary analysis, sulfonamide antibiotics (adjusted odds ratio [aOR], 2.9; 95% CI, 2.7-3.1) and cephalosporins (aOR, 2.6; 95% CI, 2.5-2.8) were most strongly associated with serious cADRs relative to macrolides. Additional associations were evident with nitrofurantoin (aOR, 2.2; 95% CI, 2.1-2.4), penicillins (aOR, 1.4; 95% CI, 1.3-1.5), and fluoroquinolones (aOR, 1.3; 95% CI, 1.2-1.4). The crude rate of ED visits or hospitalization for cADRs was highest for cephalosporins (4.92 per 1000 prescriptions; 95% CI, 4.86-4.99) and sulfonamide antibiotics (3.22 per 1000 prescriptions; 95% CI, 3.15-3.28). Among the 2852 case patients hospitalized for cADRs, the median length of stay was 6 days (IQR, 3-13 days), 9.6% required transfer to a critical care unit, and 5.3% died in the hospital. Conclusion and Relevance Commonly prescribed oral antibiotics are associated with an increased risk of serious cADRs compared with macrolides, with sulfonamides and cephalosporins carrying the highest risk. Prescribers should preferentially use lower-risk antibiotics when clinically appropriate.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
故意的颜完成签到,获得积分10
1秒前
平淡大叔发布了新的文献求助10
1秒前
清脆若雁完成签到 ,获得积分10
1秒前
落桑发布了新的文献求助10
3秒前
3秒前
3秒前
觉醒之义发布了新的文献求助10
4秒前
echo完成签到 ,获得积分10
5秒前
KneeYu应助djf采纳,获得20
5秒前
所所应助南桥采纳,获得10
6秒前
hsbuuwqbdubeq发布了新的文献求助10
7秒前
12秒前
Ava应助哑巴采纳,获得10
13秒前
乐乐应助麦斯采纳,获得10
13秒前
斯文败类应助平淡大叔采纳,获得10
14秒前
wongcheng完成签到,获得积分10
16秒前
彭于晏应助美好沛萍采纳,获得10
19秒前
19秒前
zho发布了新的文献求助30
22秒前
Yxian完成签到,获得积分20
22秒前
23秒前
故意的颜发布了新的文献求助30
24秒前
24秒前
24秒前
lzl完成签到,获得积分10
25秒前
李花开又白完成签到 ,获得积分10
25秒前
28秒前
perrin发布了新的文献求助10
28秒前
西瓜不呱发布了新的文献求助10
29秒前
29秒前
33秒前
33秒前
胖哥发布了新的文献求助10
33秒前
RAmos_1982完成签到,获得积分10
34秒前
34秒前
35秒前
qt91发布了新的文献求助10
35秒前
慕青应助fheu采纳,获得10
36秒前
36秒前
顾矜应助睡不醒的喵采纳,获得10
37秒前
高分求助中
LNG地下式貯槽指針(JGA指-107) 1000
LNG地上式貯槽指針 (JGA指 ; 108) 1000
Generalized Linear Mixed Models 第二版 1000
Preparation and Characterization of Five Amino-Modified Hyper-Crosslinked Polymers and Performance Evaluation for Aged Transformer Oil Reclamation 700
Operative Techniques in Pediatric Orthopaedic Surgery 510
九经直音韵母研究 500
Full waveform acoustic data processing 500
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 免疫学 细胞生物学 电极
热门帖子
关注 科研通微信公众号,转发送积分 2928114
求助须知:如何正确求助?哪些是违规求助? 2577574
关于积分的说明 6956049
捐赠科研通 2227990
什么是DOI,文献DOI怎么找? 1184134
版权声明 589399
科研通“疑难数据库(出版商)”最低求助积分说明 579453